Another reason to undertake these studies was to determine if the use of serologically distinct Ad4 based malaria targeted vaccines might allow for improved induction of CSP immune responses, relative to repeated use of Ad5, in Ad5 immune animals. This evidence concerns the gene DNAJC5 and malaria.